[KROS] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[KROS] Keros Therapeutics, Inc.
Announcement Date
03-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -56.08%
YoY- -328.24%
Quarter Report
KROS's Result
KROS's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 8 0 0 0 0 100 0 -
PBT -39,440 -37,505 -35,804 -29,718 -23,509 -27,266 -24,186 38.50%
Tax -210 3,832 -3,065 2 -4,467 -3,462 1 -
NP -39,440 -37,505 -32,739 -29,720 -19,042 -23,804 -24,187 38.49%
Tax Rate - - - - - - - -
Total Cost 39,448 37,505 32,739 29,720 19,042 23,904 24,187 38.51%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -493,000.00 0.00 0.00 0.00 0.00 -23,804.00 0.00 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -1.33 -1.27 -1.15 -1.09 -0.75 -0.99 -1.01 20.11%
EPS Diluted -1.33 -1.27 -1.15 -1.09 -0.75 -0.99 -1.01 20.11%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.